Insensitivity to T790M mutation? A pooled analysis of outcomes following osimertinib for the treatment of NSCLC patients harboring uncommon epidermal growth factor receptor mutation

Background: In this pooled analysis, the aim was to investigate the clinicopathological characteristics of patients with uncommon epidermal growth factor receptor (EGFR) (ucm-EGFRms) along with their treatment responses and survival following osimertinib treatment. Methods: Univariate chi-square ana...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Shanliang, Wang, Congjie, Wang, Chunsheng, Zhao, Kewei, Wang, Zhen, Dong, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9458881/
https://www.ncbi.nlm.nih.gov/pubmed/36091840
http://dx.doi.org/10.3389/fphar.2022.986962

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9458881/
https://www.ncbi.nlm.nih.gov/pubmed/36091840
http://dx.doi.org/10.3389/fphar.2022.986962

Ejemplares similares